Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8–12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.
The report details the trend, potential and market size of Rivaroxaban market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Rivaroxabanmarket, defines the market attractiveness level of Rivaroxaban market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Rivaroxaban industry, describes the types of Rivaroxaban market, the applications of major players and the market size, and deeply analyzes the current situation of the global Rivaroxaban market and the development prospects and opportunities of Rivaroxaban industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Rivaroxaban market in Chapter 13.
By Player:
Bayer
J&J
By Type:
10 mg
15 mg
20 mg
By End-User:
Acute Coronary Syndrome (ACS)
Venous Thromboembolism (VTE)
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Rivaroxaban Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Rivaroxaban Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Rivaroxaban Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Rivaroxaban Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Rivaroxaban Market Analysis and Outlook to 2022
-
7.1 Global Rivaroxaban Consumption (2017-2022)
-
7.2 United States Rivaroxaban Consumption (2017-2022)
-
7.3 Europe Rivaroxaban Consumption (2017-2022)
-
7.4 China Rivaroxaban Consumption (2017-2022)
-
7.5 Japan Rivaroxaban Consumption (2017-2022)
-
7.6 India Rivaroxaban Consumption (2017-2022)
-
7.7 South Korea Rivaroxaban Consumption (2017-2022)
8 Region and Country-wise Rivaroxaban Market Analysis and Outlook to 2028
-
8.1 Global Rivaroxaban Consumption Forecast (2022-2028)
-
8.2 United States Rivaroxaban Consumption Forecast (2022-2028)
-
8.3 Europe Rivaroxaban Consumption Forecast (2022-2028)
-
8.4 China Rivaroxaban Consumption Forecast (2022-2028)
-
8.5 Japan Rivaroxaban Consumption Forecast (2022-2028)
-
8.6 India Rivaroxaban Consumption Forecast (2022-2028)
-
8.7 South Korea Rivaroxaban Consumption Forecast (2022-2028)
9 Global Rivaroxaban Market Outlook by Types and Applications to 2022
-
9.1 Global Rivaroxaban Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 10 mg Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 15 mg Consumption and Growth Rate (2017-2022)
-
9.1.3 Global 20 mg Consumption and Growth Rate (2017-2022)
-
9.2 Global Rivaroxaban Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Acute Coronary Syndrome (ACS) Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Venous Thromboembolism (VTE) Consumption and Growth Rate (2017-2022)
10 Global Rivaroxaban Market Outlook by Types and Applications to 2028
-
10.1 Global Rivaroxaban Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 10 mg Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 15 mg Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global 20 mg Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Rivaroxaban Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Acute Coronary Syndrome (ACS) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Venous Thromboembolism (VTE) Consumption Forecast and Growth Rate (2022-2028)
11 Global Rivaroxaban Import and Export Analysis (Top 5 Countries)
-
11.1 Global Rivaroxaban Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Rivaroxaban Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Rivaroxaban Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Rivaroxaban Market Competitive Analysis
-
14.1 Bayer
-
14.1.1 Bayer Company Details
-
14.1.2 Bayer Rivaroxaban Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bayer Rivaroxaban Product and Service
-
14.2 J&J
-
14.2.1 J&J Company Details
-
14.2.2 J&J Rivaroxaban Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 J&J Rivaroxaban Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Rivaroxaban
-
Figure Rivaroxaban Picture
-
Table Global Rivaroxaban Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Rivaroxaban Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Rivaroxaban Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Rivaroxaban Consumption by Country (2017-2022)
-
Figure United States Rivaroxaban Consumption and Growth Rate (2017-2022)
-
Table Europe Rivaroxaban Consumption and Growth Rate (2017-2022)
-
Figure China Rivaroxaban Consumption and Growth Rate (2017-2022)
-
Figure Japan Rivaroxaban Consumption and Growth Rate (2017-2022)
-
Figure India Rivaroxaban Consumption and Growth Rate (2017-2022)
-
Figure South Korea Rivaroxaban Consumption and Growth Rate (2017-2022)
-
Figure Global Rivaroxaban Consumption Forecast by Country (2022-2028)
-
Figure United States Rivaroxaban Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Rivaroxaban Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Rivaroxaban Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Rivaroxaban Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Rivaroxaban Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Rivaroxaban Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 10 mg Consumption and Growth Rate (2017-2022)
-
Figure Global 15 mg Consumption and Growth Rate (2017-2022)
-
Figure Global 20 mg Consumption and Growth Rate (2017-2022)
-
Figure Global Acute Coronary Syndrome (ACS) Consumption and Growth Rate (2017-2022)
-
Figure Global Venous Thromboembolism (VTE) Consumption and Growth Rate (2017-2022)
-
Figure Global 10 mg Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 15 mg Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 20 mg Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acute Coronary Syndrome (ACS) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Venous Thromboembolism (VTE) Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Rivaroxaban Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Rivaroxaban Export by Region (Top 5 Countries) (2017-2028)
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Rivaroxaban Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Rivaroxaban Product and Service
-
Table J&J (Foundation Year, Company Profile and etc.)
-
Table J&J Rivaroxaban Sales, Price, Value and Gross Profit (2017-2022)
-
Table J&J Rivaroxaban Product and Service
-
